Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
Research Centre (BRC) programme is Precision Cardiovascular Genomic Medicine, co-led by Professors Panos Deloukas and Patricia Munroe. Our research focuses on (i) deep phenotyping with multi-omics and
-
locally-employed laboratory personnel, ensuring all laboratory activities related to the LSHTM-COMAHS programme and ancillary and future studies are performed in strict accordance to Good Clinical
-
programme. About the CoSTAR National Lab : The CoSTAR National Lab is the largest ever investment in creative industries R&D by UKRI. A £51.1m programme led by Royal Holloway, University of London to develop
-
pay benefit, free on-site gym and wellbeing centre a comprehensive learning and development programme and support for your CPD Prospective applicants are encouraged in the first instance to contact
-
About the Project We are seeking a talented and dedicated team of scientists, bioinformaticians and support colleaguesto join the ground-breaking PharosAI initiative – a £43.6M national programme co
-
About the Role To provide professional support for all UG students in the School of Economics and Finance, and to provide programme management support for the portfolio of UG programmes. The post
-
assist with the delivery of teaching across the programme and will have the opportunity to co-lead a module. You will also assist with assessment and student support duties. The post holder will be
-
. Provide full customer service to all applicants including advising and guiding candidates through the admissions process, positively influencing their views of our Programme and School. Arranging interviews
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing